? e-coli ?
https://www.google.com/search?q=antibacterial+resistant+bacteria+e-coli+from+human+feces&rlz=1C1CHZN_enNZ947NZ947&ei=PFSwZOmjA8XV1e8Px_ausAw&ved=0ahUKEwjpscWKuYyAAxXFavUHHUe7C8YQ4dUDCBA&uact=5&oq=antibacterial+resistant+bacteria+e-coli+from+human+feces&gs_lcp=Cgxnd3Mtd2l6LXNlcnAQAzIFCAAQogQyBQgAEKIEMgUIABCiBDIFCAAQogQyBQgAEKIEOgoIABBHENYEELADSgQIQRgAUJRgWOF4YLl8aANwAHgAgAHWAYgBjgaSAQUwLjIuMpgBAKABAcABAcgBCA&sclient=gws-wiz-serp
https://www.pharmaceutical-technology.com/uncategorized/recce-327-recce-pharmaceuticals-escherichia-coli-infections-likelihood-of-approval/
.
- Forums
- ASX - By Stock
- Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.61%
!
30.5¢

? e-coli...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.005(1.61%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
30.5¢ | 32.0¢ | 30.5¢ | $20.19K | 65.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4391 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 1289 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 455 | 0.300 |
3 | 35728 | 0.295 |
3 | 13198 | 0.290 |
5 | 233518 | 0.285 |
11 | 293389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 1289 | 2 |
0.315 | 13035 | 3 |
0.320 | 1013 | 2 |
0.330 | 114230 | 1 |
0.350 | 31000 | 3 |
Last trade - 10.17am 26/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online